戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e of dietary Se and as an upgraded source of isoflavonoids.
2 ors of ecologically important flavonoids and isoflavonoids.
3 opanoid pathway that produces flavonoids and isoflavonoids.
4  the various important bioactive lignans and isoflavonoids.
5 iogenetic relationships between the modified isoflavonoids 1-11 are proposed, and a cyclization react
6                                              Isoflavonoids 26-28 showed moderate (IC50 7-30 microM) b
7 methylation that converts the pterocarpanoid isoflavonoid 6a-hydroxymaackiain to pisatin.
8 vestigate the role of the small intestine in isoflavonoid absorption and metabolism in humans.
9                                              Isoflavonoid absorption from the gut requires deconjugat
10 ere fed a single soy meal containing 64.8 mg isoflavonoid aglycone equivalents (95% as glucosides).
11            Chyme contained 36.7% of ingested isoflavonoid aglycone equivalents, primarily (95.8%) as
12           To determine the contents of these isoflavonoids, an efficient analytical LC-MS (TOF) techn
13 ption was assessed indirectly by quantifying isoflavonoids and several metabolites in 24-h urine pool
14                  Extracts rich in prenylated isoflavonoids and stilbenoids showed potent antibacteria
15                                In flavonoid, isoflavonoid, and anthocyanin biosynthesis, chalcone iso
16 edicago truncatula) glycosylates flavonoids, isoflavonoids, and triterpenes.
17 asmid to increase anti-tumor efficacy of the isoflavonoid apigenin (APG) in human malignant neuroblas
18                                              Isoflavonoids are a class of phenylpropanoids made by le
19                                              Isoflavonoids are a group of secondary metabolites commo
20                                  In soybean, isoflavonoids are a key rhizodeposit component that aid
21                                              Isoflavonoids are commonly found in leguminous plants, w
22 ds, whereas the isoflavone reductase-derived isoflavonoids are mainly restricted to the Fabaceae, it
23                               Flavonoids and isoflavonoids are major plant secondary metabolites that
24                                              Isoflavonoids are thought to play an important role in s
25 s consistent with the physiological roles of isoflavonoids as defense compounds against pathogens and
26 transcription factors involved in regulating isoflavonoid biosynthesis in Lotus (Lotus japonicus).
27 ct O-methyltransferases (OMTs) implicated in isoflavonoid biosynthesis in Medicago species, a 7-OMT m
28                                              Isoflavonoid biosynthesis was silenced via RNA interfere
29 nzyme catalyzing the first committed step of isoflavonoid biosynthesis, various chalcone substrates a
30   Our aim is to understand the regulation of isoflavonoid biosynthesis.
31 o the main subgroup 2 have roles in inducing isoflavonoid biosynthesis.
32  to P. sojae; furthermore, the expression of isoflavonoid biosynthetic genes was drastically reduced
33 ytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.
34 arpus, were investigated for inducibility of isoflavonoids by germination with or without subsequent
35                                              Isoflavonoid compositions, phenylalanine ammonia lyase (
36                                None of the 3 isoflavonoid compounds administered orally affected live
37  Puerarin, daidzin, and daidzein are 3 major isoflavonoid compounds isolated from Pueraria lobata, an
38 romyces cerevisiae) to produce flavonoid and isoflavonoid compounds.
39  made by legumes, and consumption of dietary isoflavonoids confers benefits to human health.
40 of Rhizopus onto the seedlings increased the isoflavonoid content considerably (in the range of 0.5-3
41 ect against oxidative stress due to its high isoflavonoid content.
42                              Exposure to the isoflavonoid coumestrol increased beta-glucuronidase act
43                             HPLC analysis of isoflavonoid-derived metabolites of the phenylpropanoid
44 e 3-O-methylation of the 6a-hydroxymaackiain isoflavonoid-derived pterocarpanoid intermediate found i
45 tocopherol, polyunsaturated fatty acids, and isoflavonoids did not differ significantly between dieta
46 ld be normalized to the aglycone mass (or an isoflavonoid equivalent) rather than a simple sum of all
47 > glycitein > genistein) and the quantity of isoflavonoid equivalents were not significantly differen
48  d of each treatment period was analyzed for isoflavonoid (equol, O-desmethylangolensin, genistein, a
49  protection has not been determined, urinary isoflavonoid excretion appears linear at low-to-moderate
50 oducts, and a dose-response study of urinary isoflavonoid excretion at the low end of soy consumption
51  in previous studies--and to compare urinary isoflavonoid excretion between equol excreters and nonex
52  purpose of our study was to measure urinary isoflavonoid excretion in response to daily consumption
53          Qualitative profiles (x +/- SEM) of isoflavonoid excretion in urine (daidzein > glycitein >
54            Our results indicate that urinary isoflavonoid excretion is dose dependent in humans at lo
55 careful design and interpretation of urinary isoflavonoid excretion studies, particularly bacterial m
56  there was a linear dose response of urinary isoflavonoid excretion to soy consumption that did not d
57 was a highly linear dose response of urinary isoflavonoid excretion to soy consumption, which did not
58 asurements, with adjustment for body weight, isoflavonoid exposure is 4-6 times higher in infants fed
59 eporter was also induced by the alfalfa root isoflavonoids formononetin and medicarpin but not by two
60  roots deficient for a subset of flavonoids, isoflavonoids (formononetin and biochanin A) and flavone
61                         Genistein, a natural isoflavonoid found in soybean products, has been propose
62 molecule Bcl-2 inhibitor HA14-1 (HA) and the isoflavonoid genistein (GST) in human malignant neurobla
63                      Among them, the soybean isoflavonoid genistein received much attention due to it
64 tro seed exudates and by the addition of the isoflavonoids genistein and daidzein.
65 Ileostomy subjects efficiently deglycosylate isoflavonoid glucosides in the small intestine and appea
66                                              Isoflavonoids had a small effect on bacterial community
67                                 Although soy isoflavonoids have a number of health-promoting benefits
68 utionary significance since both lignans and isoflavonoids have comparable plant defense properties,
69                  In addition, flavonoids and isoflavonoids have direct but complex effects on human h
70 oid cases and 173 controls were analyzed for isoflavonoids (ie, daidzein, genistein, equol, and O-des
71                     Genistein is a prominent isoflavonoid in soy products and has been proposed as th
72 array ultraviolet scanning to quantitate soy isoflavonoids in foods and in human plasma, urine, and b
73  Despite the importance of plant lignans and isoflavonoids in human health protection (e.g. for both
74    This observation suggests novel roles for isoflavonoids in nodulation.
75 ntial involvement of 2'- and 3'-hydroxylated isoflavonoids in pathogen defense and insect-induced res
76 lant by reducing the accumulation of alfalfa isoflavonoids in the bacterial cells.
77                      The cytotoxic effect of isoflavonoids in the development of different forms of c
78                                Metabolism of isoflavonoids in the upper gastrointestinal tract was ex
79  species that also produce B-ring methylated isoflavonoids in vivo.
80        Mutant strain I-1 was isolated by its isoflavonoid-inducible neomycin resistance following mut
81 c parameters for the 4'-O-methylation of the isoflavonoid intermediate 2,7,4'-trihydroxyisoflavanone
82                       4'-O-Methylation of an isoflavonoid intermediate is a key reaction in the biosy
83 , the production of microbial metabolites of isoflavonoids is limited in ileostomy subjects.
84          Nematode infection had no effect on isoflavonoid levels.
85 ys, and Medicago-specific pathways including isoflavonoid, lignin and triterpene saponin biosynthesis
86  induction of phenylpropanoid, flavonoid and isoflavonoid metabolic pathway genes involved in the pro
87 avone reductase, a key branchpoint enzyme in isoflavonoid metabolism and primarily found in the Fabac
88 id pathway, suggest new pathways for complex isoflavonoid metabolism, and indicate differential mecha
89 ckpea (Cicer arietinum), 4'-O-methylation of isoflavonoid natural products occurs early in the biosyn
90 ty for the 4' and 7-hydroxyl moieties of the isoflavonoid nucleus.
91                                The bioactive isoflavonoids of the Leguminosae often are methylated on
92 ochemical biosensor for studying the role of isoflavonoids on A549 lung adenocarcinoma cell line.
93 y the type, level, and specific influence of isoflavonoids on cells.
94         Compared to untreated sprouts, total isoflavonoid, PAL activity and antioxidant capacity show
95 empting to speculate that this branch of the isoflavonoid pathway arose via evolutionary divergence f
96 ts in increased induction of phenylpropanoid/isoflavonoid pathway gene transcripts after infection bu
97 ghlight the metabolic flexibility within the isoflavonoid pathway, suggest new pathways for complex i
98 nges in expression of confirmed genes of the isoflavonoid pathway.
99 es to endomembranes after elicitation of the isoflavonoid pathway.
100 bolic channeling at the entry point into the isoflavonoid pathway.
101  in vivo reconstruction of the flavonoid and isoflavonoid pathways in yeast provides a unique platfor
102 d enzymes in the general phenylpropanoid and isoflavonoid pathways.
103 scription rates of genes encoding enzymes of isoflavonoid phytoalexin biosynthesis and related pathwa
104 firm that daidzein is not an intermediate in isoflavonoid phytoalexin biosynthesis in alfalfa.
105 metabolic channeling at the entry point into isoflavonoid phytoalexin biosynthesis protects an unstab
106 l legume Medicago truncatula accumulated the isoflavonoid phytoalexin medicarpin in response to yeast
107 one in the biosynthesis of the antimicrobial isoflavonoid phytoalexin medicarpin.
108 ymbiosis), and in defense against pathogens (isoflavonoid phytoalexins).
109 he wide individual variation seen in urinary isoflavonoid phytoestrogen excretion, we conducted a ser
110                                              Isoflavonoids play important roles in plant defense and
111                    Prenylated flavonoids and isoflavonoids possess antimicrobial activity against fun
112 oalexin medicarpin, coordinated increases in isoflavonoid precursors were only observed for YE and no
113                            In this study, an isoflavonoid prenyltransferase gene, designated as LaPT1
114      However, only a few plant flavonoid and isoflavonoid prenyltransferase genes have been identifie
115 red high homologies with known flavonoid and isoflavonoid prenyltransferases.
116 ional domains similar to other flavonoid and isoflavonoid prenyltransferases; it has a predicted chlo
117                     Pisatin is a fungistatic isoflavonoid produced by garden pea (Pisum sativum), a h
118             Germination alone poorly induced isoflavonoid production (in the range of 0.2-0.7 mg repr
119                             The induction of isoflavonoid production in L. japonicus also involves th
120 ted during four days at 24 degrees C and the isoflavonoid profiles and concentrations evaluated by HP
121 of the product fed but increased the urinary isoflavonoid recovery, suggesting that fermentation incr
122 bstrates, are coordinately regulated with an isoflavonoid-specific gene and specifically activated by
123                The inducibility of different isoflavonoid subclasses in seedlings with Rhizopus varie
124 viously identified as showing preference for isoflavonoid substrates in vitro, was strongly up-regula
125 ic activity against a range of flavonoid and isoflavonoid substrates using a high-throughput HPLC ass
126 IOMT) in the biosynthesis of 4'-O-methylated isoflavonoids such as the phytoalexin medicarpin in vivo
127 nary excretion of daidzein, genistein, total isoflavonoids (TIFLs), and equol (measured by HPLC/photo
128 protein intake from 24-h recalls and urinary isoflavonoids were 0.72 (0.43, 0.96) for daidzein, 0.67
129 erence returned to baseline levels after the isoflavonoids were discontinued.
130                                      Urinary isoflavonoids were measured by isotope-dilution gas chro
131 action condition for the maximum recovery of isoflavonoids with high cyto-protective effect was optim

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top